Financials
Financial year 2025
DR. SCHERPENBERG from Bilzen-Hoeselt, company number BE0887033029, closed financial year 2025 with a result of € 54,281 after tax. For that financial year DR. SCHERPENBERG recorded a gross margin of € 87,517 and equity of € 241,424. Compared with financial year 2024, the result moved from € 35,854 to € 54,281. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 4, 2025.
€ 241,424
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 54,281
▲ 51% vs 2024
Profit after tax over the fiscal year.
€ 193,332
▲ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 55,230 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 10,815
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 6,686
▲ 9% vs 2024
Loans from banks and other lenders, long and short.
€ 5,055
▲ 90% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,315
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 55,308 | € 50,537 | € 58,947 | € 87,517 | ▲ 48% |
| Profit after taxes | € 33,241 | € 32,101 | € 35,854 | € 54,281 | ▲ 51% |
| Equity | € 212,337 | € 206,518 | € 242,372 | € 241,424 | |
| Total debts | € 8,279 | € 15,296 | € 12,987 | € 70,092 | ▲ € 57,104 |
| Cash | € 186,027 | € 113,167 | € 134,484 | € 193,332 | ▲ 44% |
| Retained profit | € 193,737 | € 187,918 | € 223,772 | € 222,824 | |
| Dividend | € 0 | € 37,920 | € 0 | € 55,230 | |
| Bank debt | € 3,903 | € 5,066 | € 6,156 | € 6,686 | ▲ 9% |
| Balance sheet total | € 220,616 | € 221,814 | € 255,359 | € 311,515 | ▲ 22% |
Key figures of DR. SCHERPENBERG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DR. SCHERPENBERG?
What happened at DR. SCHERPENBERG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 54,281 (▲ 51% vs 2024). Source: NBB ↗
- New establishment in Bilzen-Hoeselt. KBO
- New establishment in Bilzen-Hoeselt. KBO
- RUDI JOZEF SCHERPENBERG became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 33,241 profit in 2022 to € 54,281 profit in 2025.
Paid € 67,518 in corporate taxes since 2022.
Best year ever: 2025, with € 54,281 profit.
Paid out € 93,150 in dividends to the owners in total.
Management
Behind DR. SCHERPENBERG is RUDI JOZEF SCHERPENBERG.
Directors
According to the 2025 annual accounts
RUDI JOZEF SCHERPENBERG
Director
since 2007
Establishments
Establishment units
Physical locations of this company
Leterweg 63
3740 Bilzen-Hoeselt
Rode Kruislaan 138
3740 Bilzen-Hoeselt
Active since 1 November 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0887.033.029
- VAT number
- BE 0887.033.029
- Registered office
- Leterweg 63, 3740 Bilzen-Hoeselt
- Names & denominations
- DR. SCHERPENBERG
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 January 2007
- Peppol
- Active · Active since 17 Nov 2025
- Activities · NACE
Activiteiten van huisartspraktijken
Overige persoonlijke diensten